1968 related articles for article (PubMed ID: 20513456)
1. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
2. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
3. [SSRIs and pregnancy: a review of the literature].
Soufia M; Aoun J; Gorsane MA; Krebs MO
Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
5. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
van der Veere CN; Bos AF
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
8. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
10. SSRI antidepressants and persistent pulmonary hypertension in newborns.
Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
[TBL] [Abstract][Full Text] [Related]
11. Safety of selective serotonin reuptake inhibitors in pregnancy.
Alwan S; Friedman JM
CNS Drugs; 2009; 23(6):493-509. PubMed ID: 19480468
[TBL] [Abstract][Full Text] [Related]
12. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].
Watanabe O
Seishin Shinkeigaku Zasshi; 2014; 116(12):996-1004. PubMed ID: 25823351
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors in pregnancy.
Bellissima V; Ververs TF; Visser GH; Gazzolo D
Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
[TBL] [Abstract][Full Text] [Related]
14. [Antidepressants-SSRIs in pregnancy and risk of major malformations: treat or not to treat].
Bellantuono C; Santone G
Recenti Prog Med; 2014 Jun; 105(6):254-61. PubMed ID: 25002286
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants in pregnancy: a systematic review.
Udechuku A; Nguyen T; Hill R; Szego K
Aust N Z J Psychiatry; 2010 Nov; 44(11):978-96. PubMed ID: 21034181
[TBL] [Abstract][Full Text] [Related]
16. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
Malm H
Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.
McDonagh M; Matthews A; Phillipi C; Romm J; Peterson K; Thakurta S; Guise JM
Evid Rep Technol Assess (Full Rep); 2014 Jul; (216):1-308. PubMed ID: 30313002
[TBL] [Abstract][Full Text] [Related]
18. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
Gentile S
Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
[TBL] [Abstract][Full Text] [Related]
19. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.
Ornoy A; Koren G
Semin Fetal Neonatal Med; 2014 Jun; 19(3):188-94. PubMed ID: 24321501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
